Quarterly Report

CORCEPT THERAPEUTICS INC Filed 2025-05-05 Acc 0001628280-25-022173

Documents 1

2025-07-31 10-Q Quarterly Report
2025-05-05 10-Q Quarterly Report
2025-05-05 8-K Results of operations · Regulation FD disclosure
2025-05-05 4 See Remarks sold 39,410 shares at an average $72.13 ($2,842,769)
2025-05-05 4 Chief Executive Officer sold 40,000 shares at an average $72.90 ($2,915,922)
2025-05-05 4 See Remarks sold 9,350 shares at $71.96 ($672,781)
2024-10-30 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading cort-20250331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…